Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANTHONY SEBBA

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1629077243
CMS profile
1178088
Location
PALM HARBOR, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$75,785.78

137 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $24,397.49 37
Lilly USA, LLC $23,549.03 55
Eli Lilly and Company $15,252.84 26
GENZYME CORPORATION $12,404.11 14
Novartis Pharmaceuticals Corporation $100.11 1
ABBVIE INC. $62.09 3
Genentech USA, Inc. $20.11 1

Page 3 of 3; records 101–137 of 137 matching records. This page contains 37 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANTHONY SEBBA

NPI 1629077243 · CMS profile ID 1178088

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

PALM HARBOR, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–137 of 137 matching records. This page contains 37 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1629077243?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANTHONY SEBBA, NPI 1629077243, CMS profile ID 1178088. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–137 of 137 matching records. This page contains 37 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1629077243?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ANTHONY SEBBA, NPI 1629077243, CMS profile ID 1178088. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–137 of 137 matching records. This page contains 37 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1629077243?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ANTHONY SEBBA, NPI 1629077243, CMS profile ID 1178088, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–137 of 137 matching records. This page contains 37 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1629077243?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

137 matching records · $75,785.78 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 137 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–137 of 137.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $215.6507/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917880263 CMS
Lilly USA, LLC $241.0607/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917880267 CMS
Lilly USA, LLC $325.3507/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917880553 CMS
Lilly USA, LLC $195.0007/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917880557 CMS
Lilly USA, LLC $241.3307/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917880941 CMS
Lilly USA, LLC $13.6507/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917880945 CMS
GENZYME CORPORATION $82.6006/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938745561 CMS
Amgen Inc. $2,400.0005/20/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939473637 CMS
Amgen Inc. $2,400.0005/20/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939473647 CMS
Amgen Inc. $400.0005/20/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939473649 CMS
GENZYME CORPORATION $3,843.0005/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938745577 CMS
GENZYME CORPORATION $303.0505/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938745579 CMS
GENZYME CORPORATION $131.3405/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938745581 CMS
GENZYME CORPORATION $734.0005/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938745583 CMS
GENZYME CORPORATION $316.9805/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938745685 CMS
GENZYME CORPORATION $29.2505/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938745687 CMS
GENZYME CORPORATION $48.0005/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938745689 CMS
Lilly USA, LLC $31.8205/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917879599 CMS
Amgen Inc. $882.0005/04/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939473643 CMS
Amgen Inc. $24.5705/02/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939473641 CMS
Amgen Inc. $123.4504/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939473645 CMS
Amgen Inc. $121.1204/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939473639 CMS
Amgen Inc. $1,600.0004/15/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939473655 CMS
Amgen Inc. $13.7404/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939473681 CMS
Lilly USA, LLC $875.0004/11/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917878571 CMS
Lilly USA, LLC $2,300.0004/11/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917879597 CMS
ABBVIE INC. $17.1304/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891555341 CMS
Lilly USA, LLC $25.3604/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917879337 CMS
Lilly USA, LLC $8.9304/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917880275 CMS
Amgen Inc. $16.7303/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940065025 CMS
GENZYME CORPORATION $1,281.0002/25/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938745545 CMS
Amgen Inc. $1,700.0002/18/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939473651 CMS
Amgen Inc. $1,800.0002/18/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939473653 CMS
ABBVIE INC. $22.9002/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891555339 CMS
Lilly USA, LLC $1,725.0002/01/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917880963 CMS
Lilly USA, LLC $455.0001/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917878573 CMS
Lilly USA, LLC $74.4601/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917879181 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $263,229.40 347
PY2020 $82,908.45 62
PY2021 $54,467.62 59
PY2022 $75,785.78 137
PY2023 $71,864.01 91
PY2024 $29,897.87 32
PY2025 $9,491.08 8

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2020 Recipient $4,366.00 5
PY2020 Principal investigator $3,274.32 2
PY2019 Recipient $1,960.00 1
PY2019 Principal investigator $9,933.81 9

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient GENZYME CORPORATION $397.50 11/07/2020 Covered Recipient Physician A randomized, double-blind, placebo-controlled, multicenter, two-part, dose ranging and confirmatory study with an operationally seamless design, evaluating efficacy and safety of SAR153191 on top of methotrexate (MTX) in patients with active rheumatoid a No dispute reported 06/30/2026 744023449
Recipient GENZYME CORPORATION $1,005.00 11/07/2020 Covered Recipient Physician A randomized, double-blind, placebo-controlled, multicenter, two-part, dose ranging and confirmatory study with an operationally seamless design, evaluating efficacy and safety of SAR153191 on top of methotrexate (MTX) in patients with active rheumatoid a No dispute reported 06/30/2026 744023457
Principal investigator 1 PFIZER INC. $2,494.32 06/18/2020 Non-covered Recipient Entity
ARTHRITIS RESEARCH OF FLORIDA INC
PHASE 3B4 RANDOMIZED SAFETY ENDPOINT STUDY OF 2 DOSES OF TOFACITINIB IN COMPARISON TO A TUMOR NECROSIS FACTOR TNF INHIBITOR IN SUBJECTS WITH RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 742932571
Recipient GENZYME CORPORATION $1,005.00 06/03/2020 Covered Recipient Physician A randomized, double-blind, parallel-group study assessing the efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis No dispute reported 06/30/2026 744023441
Principal investigator 1 Eli Lilly and Company $780.00 05/19/2020 Non-covered Recipient Entity
ARTHRITIS RESEARCH OF FLORIDA INC
A PHASE 3 MULTICENTER STUDY TO EVALUATE THE LONG TERM SAFETY AND EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 728732707
Recipient F. Hoffmann-La Roche AG $1,561.00 03/31/2020 Covered Recipient Physician Pain and Other Patient-Reported Outcomes in Patients With Rheumatoid Arthritis Who Did or Did Not Achieve Treatment Response Based on Improvement in Swollen Joints in Tocilizumab Clinical Trials No dispute reported 06/30/2026 742973935
Recipient SANOFI-AVENTIS U.S. LLC $397.50 03/30/2020 Covered Recipient Physician Noninflammatory pain is a frequent phenomenon in rheumatoid arthritis and responds well to treatment with sarilumab No dispute reported 06/30/2026 744023433